Unstable cell conditions, fluctuating experimental data... In countless late nights, have you ever blamed experimental failures on cell condition, serum batches, or even your own techniques? Yet you may have overlooked the most fundamental and critical variable: the quality of cytokines.

A reliable cytokine should not be an experimental variable but a constant. This is precisely why Yeasen Biotech created the HiActi™ High-Activity Cytokine Series: to minimize uncertainty and allow research to focus on exploration itself.

As a high-tech enterprise deeply rooted in life sciences, Yeasen Biotechnology leverages its professional R&D team, advanced production platforms, and stringent quality control systems. The company has built substantial technical expertise and market reputation in core product areas including cytokines, enzymes, and antibodies. The launch of the HiActi™ cytokine series embodies Yeasen Biotech's precise insight into research needs and concentrated technological strength. From R&D to production, quality inspection to delivery, every step demonstrates the brand's relentless pursuit of excellence.

“Three Highs” Core Strengths, Solve Key Research Pain Points

1. High Activity: Accelerate Experiments, Double Efficiency

  • Technical Assurance: Innovative preparation processes precisely preserve natural protein conformation. Rigorous bioactivity validation ensures industry-leading potency in every batch.
  • Your Benefits: Achieve optimal results with lower dosages, significantly reducing experimental costs; Rapid activation of cellular signaling pathways shortens reaction times; Exceptional batch-to-batch consistency ensures reliable long-term experimental projects.

2. High Purity: Precise Empowerment, Reliable Outcomes

  • Technical Assurance: Employing multi-step chromatographic purification, final product purity is validated via SDS-PAGE and HPLC at > 95%, even > 98%; endotoxin levels are strictly controlled at an extremely low level of < 0.01 EU/μg, far below industry standards.
  • Your Benefits: Eliminates interference from contaminating proteins, ensuring experimental specificity; ultra-low endotoxin levels are particularly suitable for sensitive cell cultures.

3. High Stability: Proven Durability with Sustained Activity

  • Technical Assurance: Utilizing specialized lyophilization techniques and stable formulations, HiActi™ cytokines maintain stability during extended storage and transportation. Accelerated degradation studies confirm activity stability for over 18 months at -20°C, with minimal loss after repeated freeze-thaw cycles.
  • Your Benefits: Eliminate complex storage management and concerns about experiment interruptions due to reagent expiration. High stability streamlines research workflows, providing continuous, reliable support for long-term research projects.

Product Data Showcase

High Activity

Figure 1.&nbsp;The results of cell proliferation stimulation assay of Human TF-1 cells showed that Human IL-3 has a specific activity of &gt;&nbsp;1.7 x 106&nbsp;IU/mg.

Figure 1. The results of cell proliferation stimulation assay of Human TF-1 cells showed that Human IL-3 has a specific activity of > 1.7 x 106 IU/mg.

High Purity

Figure 2.&nbsp;Human IL-3 protein on SDS-PAGE: the purity is greater than 95%.

Figure 2. Human IL-3 protein on SDS-PAGE: the purity is greater than 95%.

High Stability

Figure 3. Cell proliferation assay of Human TF-1 cells shows that Human IL-3 protein is stable at 37℃ for 48 hours after reconstitution.

Figure 3. Cell proliferation assay of Human TF-1 cells shows that Human IL-3 protein is stable at 37℃ for 48 hours after reconstitution.

Figure 4. Cell activity assay results show that Human IL-3 protein is stable after repeated freezing and thawing for 3 times.

Figure 4. Cell activity assay results show that Human IL-3 protein is stable after repeated freezing and thawing for 3 times.

Figure 5. Human IL-3 cell activity of different batches remains consistent with high batch-to-batch consistency.

Figure 5. Human IL-3 cell activity of different batches remains consistent with high batch-to-batch consistency.

Application Case Showcase

Yeasen HiActi™ Cytokines (90213ES/90147ES/90218ES/93210ES/91102ES) deliver precise efficacy, empowering breakthroughs by Professor Yi Fan's group from the School of Basic Medical Sciences, Shandong University and Professor Shen Pingping's group from Nanjing University, resulting in high-impact publications!

In scientific research, efficiency and precision are equally indispensable. Yeasen Biotech's HiActi™ cytokines, with triple strengths of “high activity, high purity, and high stability,” clear obstacles and empower researchers, becoming the “hardcore partner” in every lab. Whether in basic research, drug development, or preclinical trials, HiActi™ cytokines deliver stable and reliable performance, ensuring every scientific exploration lands precisely and every innovation emerges faster.

Choose Yeasen Biotech's HiActi™ Cytokines, choose a new paradigm of efficient research—let us join hands and embark on a new scientific journey together!

Order Information

Name

Cat. No.

Size

Recombinant Human IL-2 Protein

90213ES

10 ug/50 ug/100 ug/1 mg

Recombinant Mouse IL-7 Protein

90147ES

10 ug/100 ug/500 ug

Mouse IL-15 Protein, His Tag

90218ES

10 ug/20 ug/50 ug/100 ug

Mouse FAP Protein, His Tag

93210ES

25 ug/100 ug/500 ug

Recombinant Human GM-CSF Protein

91102ES

50 ug/100 ug/500 ug/1 mg

Forespørgsel